n-Lorem Foundation Celebrates Five Years of Innovation for Nano-Rare Diseases
n-Lorem Foundation Celebrates Five Years of Innovation for Nano-Rare Diseases In an era where access to highly specialized medical treatments is often hindered by costs, timelines, and logistical constraints, the…
Eyestem’s Eyecyte-RPE™ Demonstrates Vision Preservation in Geographic Atrophy Clinical Trial
Eyestem’s Eyecyte-RPE™ Demonstrates Vision Preservation in Geographic Atrophy Clinical Trial Bangalore-based biotech firm Eyestem Research has reported highly encouraging results from its Phase 1 clinical trial evaluating Eyecyte-RPE™, a novel…
Atelerix Partners with MineBio to Distribute Cell Preservation Solutions in China
Atelerix Partners with MineBio to Distribute Cell Preservation Solutions in China UK-based biotech innovator Atelerix partners with MineBio to bring next-generation ambient-temperature cell preservation to the world’s fastest-growing biopharma market.…
Nuclera Enhances eProtein Platform to Support Membrane Protein Production
Nuclera Enhances eProtein Platform to Support Membrane Protein Production Nuclera, a leading biotechnology innovator specializing in rapid protein expression and optimization, today announced a significant enhancement to its flagship benchtop…
Spectrum Vascular Appoints New Executive Leadership Team
Spectrum Vascular Appoints New Executive Leadership Team Spectrum Vascular, a fast-growing provider of vascular access and medication management products designed to reduce healthcare-associated infections (HAIs), has announced the appointment of…
ATED Therapeutics Develops Quick and Easy Blood Test for Detecting Parkinson’s Disease
ATED Therapeutics Develops Quick and Easy Blood Test for Detecting Parkinson’s Disease In a significant stride toward revolutionizing the diagnosis and monitoring of Parkinson’s disease (PD), UK-based biotech company ATED…
Soleo Health Named Exclusive Specialty Pharmacy for Qfitlia™ in Hemophilia Treatment
Soleo Health Named Exclusive Specialty Pharmacy for Qfitlia™ in Hemophilia Treatment Bringing a first-in-class antithrombin-lowering therapy to patients with hemophilia A or B, Soleo Health reinforces its leadership in specialty…
IPUMP Enhances Compliance in SLIT Treatment
IPUMP Enhances Compliance in SLIT Treatment Stallergenes Greer, a global leader in allergy diagnostics and immunotherapy, has announced that it will present compelling findings from its SPEED survey at the…
Aulos Bioscience Begins Phase 2 Dosing of AU-007 and Nivolumab Combo for Melanoma
Aulos Bioscience Begins Phase 2 Dosing of AU-007 and Nivolumab Combo for Melanoma Immuno-oncology innovator Aulos Bioscience has initiated dosing in a new cohort of its ongoing Phase 1/2 clinical…
Mirum Receives FDA Approval for Tablet Version of LIVMARLI
Mirum Receives FDA Approval for Tablet Version of LIVMARLI In a significant advancement for the rare liver disease community, Mirum Pharmaceuticals, Inc. announced today that the U.S. Food and Drug…
New Study Exposes Harmful Effects of IRA’s ‘Pill Penalty’ on Small Molecule Drugs
New Study Exposes Harmful Effects of IRA’s ‘Pill Penalty’ on Small Molecule Drugs A recently published peer-reviewed study is shedding light on the unintended yet far-reaching consequences of the Inflation…
Exicure Approaches Phase 2 Completion for GPC-100 in Multiple Myeloma Treatment
Exicure Approaches Phase 2 Completion for GPC-100 in Multiple Myeloma Treatment Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company advancing novel small molecule therapeutics for immuno-oncology and hematological malignancies, announced…